ATE254481T1 - Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie - Google Patents

Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie

Info

Publication number
ATE254481T1
ATE254481T1 AT96400493T AT96400493T ATE254481T1 AT E254481 T1 ATE254481 T1 AT E254481T1 AT 96400493 T AT96400493 T AT 96400493T AT 96400493 T AT96400493 T AT 96400493T AT E254481 T1 ATE254481 T1 AT E254481T1
Authority
AT
Austria
Prior art keywords
chitosan complex
cancer
radioactive
radiation therapy
radioactive chitosan
Prior art date
Application number
AT96400493T
Other languages
English (en)
Inventor
Kyoung-Bae Park
Young-Mi Kim
Jae-Rock Kim
Original Assignee
Korea Atomic Energy Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Atomic Energy Res filed Critical Korea Atomic Energy Res
Application granted granted Critical
Publication of ATE254481T1 publication Critical patent/ATE254481T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96400493T 1995-03-10 1996-03-08 Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie ATE254481T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19950004872 1995-03-10
KR1019960005038A KR100190957B1 (ko) 1995-03-10 1996-02-28 방사성 키토산 착물, 방사성 키토산 응집입자 및 방사성키토산 착물 제조용 키트, 그리고 그들의 제조방법 및 용도

Publications (1)

Publication Number Publication Date
ATE254481T1 true ATE254481T1 (de) 2003-12-15

Family

ID=26630908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96400493T ATE254481T1 (de) 1995-03-10 1996-03-08 Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie

Country Status (8)

Country Link
EP (1) EP0730871B1 (de)
JP (1) JP3048915B2 (de)
KR (1) KR100190957B1 (de)
CN (3) CN1131072C (de)
AT (1) ATE254481T1 (de)
DE (1) DE69630727T2 (de)
DK (1) DK0730871T3 (de)
PT (1) PT730871E (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
KR100530276B1 (ko) * 1998-10-12 2006-02-28 서울대학교병원 입자성 방사성핵종 포합 중합체, 그 제조방법 및 그 제조용킷트
US6660247B1 (en) 2000-06-23 2003-12-09 Battelle Memorial Institute Multiple stimulus reversible hydrogels
US20040197264A1 (en) * 2003-04-04 2004-10-07 Alexander Schwarz Microspheres comprising therapeutic and diagnostic radioactive isotopes
WO2005023316A1 (en) * 2003-09-08 2005-03-17 Dong Wha Pharm., Ind., Co., Ltd. A radioisotope-chitosan complex for treatment of prostate cancer
KR101080056B1 (ko) * 2004-12-01 2011-11-04 한국원자력연구원 체내 주사시 겔화 안정성이 개선된 방사성물질-키토산복합체용액 조성물 및 그 제조 방법
KR100704548B1 (ko) 2005-10-31 2007-04-09 한국과학기술연구원 염증 부위 특이적 고분자 유도체 및 그의 용도
CN100450553C (zh) * 2006-11-16 2009-01-14 沈阳 可降解放射性海绵及其制造工艺
NL2009688C2 (en) * 2012-10-24 2014-04-29 Nucletron Operations Bv A settable radioactive gel, a method of manufacturing a settable radioactive gel, a device for manufacturing a settable radioactive gel.
US10799587B2 (en) * 2016-05-11 2020-10-13 Huan NIU Ion implantation of neutron capture elements into nanodiamond particles to form composition for neutron capture therapy usage
CN107811752A (zh) * 2017-09-21 2018-03-20 温州医科大学 一种生物相容性青光眼房水引流管及其制备方法
KR101977185B1 (ko) * 2017-11-07 2019-05-10 한국원자력연구원 난치성 질환 치료 및 진단을 위한 생체 내 발생기 기능을 갖는 마이크로입자
WO2022066546A1 (en) * 2020-09-22 2022-03-31 Swimc Llc Chitosan-containing coating compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
JPH01211529A (ja) * 1988-02-19 1989-08-24 Tomoji Tanaka キチン、キトサン化合物を基材とした薬剤
US5061476A (en) * 1989-12-27 1991-10-29 The Dow Chemical Company Radiolabeled colloid compositions and method for preparing same
US5336415A (en) 1993-02-10 1994-08-09 Vanson L.P. Removing polyvalent metals from aqueous waste streams with chitosan and halogenating agents
JP3727074B2 (ja) * 1993-10-26 2005-12-14 日本メジフィジックス株式会社 局所投与放射線治療剤

Also Published As

Publication number Publication date
JPH08311105A (ja) 1996-11-26
CN1139116A (zh) 1997-01-01
EP0730871A1 (de) 1996-09-11
CN1131072C (zh) 2003-12-17
JP3048915B2 (ja) 2000-06-05
CN1343522A (zh) 2002-04-10
PT730871E (pt) 2004-07-30
DE69630727D1 (de) 2003-12-24
CN1196498C (zh) 2005-04-13
CN1343521A (zh) 2002-04-10
KR100190957B1 (ko) 1999-06-15
DE69630727T2 (de) 2004-09-30
DK0730871T3 (da) 2004-07-26
CN100528242C (zh) 2009-08-19
EP0730871B1 (de) 2003-11-19
KR960033472A (ko) 1996-10-22

Similar Documents

Publication Publication Date Title
BR9915080A (pt) Fonte radioativa para uso em braquiterapia, métodos para a preparação de uma fonte radioativa e para tratamento de uma condição que responde à terapia de radiação, e, composição
US5484778C1 (en) Phthalocynine photosensitizers for photodynamic therapy and methods for their use
ATE254481T1 (de) Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie
IL83012A0 (en) Immunoconjugates for use in tumor therapy and their production
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
EP0423228A4 (en) Immunoconjugates for cancer diagnosis and therapy
BG102657A (en) Method for radiation retention by means of fullerene molecules
FI972546A (fi) Ristiinsidotut mikropartikkelit ja niiden käyttö hoitavina apuaineina
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
PL308074A1 (en) Derivatives of borone peptides, their production as well as their application in medical therapy
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
WO1997005904A3 (de) Verwendung von metall-clustern als kontrastmittel oder strahlentherapeutikum
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CA2320138A1 (en) Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereof
KR960033481A (ko) 피부질환 치료용 방사성팻취와 그 제조방법
BG51097A1 (en) Process for the preparation of radiosensibilizing agent
RU94035764A (ru) Способ лечения онкологического заболевания
ATE80800T1 (de) Verwendung von suramin und physiologisch vertraeglichen derivaten davon, gegebenenfalls in kombination mit anti-androgenen mitteln zur herstellung von arzneimitteln zur behandlung des humanen prostatakarzinoms.
BG51098A1 (en) Process for producing of radiosensibilizing compound
BG50534A1 (en) Method for the radio protection of biological objects under fractional and prolonged irradiation conditions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEWE Authorization for restitution
UEP Publication of translation of european patent specification

Ref document number: 0730871

Country of ref document: EP